MYGN FY 2025 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$487M

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$825M-1.6% YoY

Gross Profit

$577M69.9% margin

Operating Income

-$139M-16.9% margin

Net Income

-$366M-44.4% margin

EPS (Diluted)

$-3.96

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$707M

Total Liabilities

$339M

Stockholders' Equity

$368M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$825M	$838M	-1.6%
Gross Profit	$577M	$585M	-1.5%
Operating Income	-$139M	-$124M	-12.8%
Net Income	-$366M	-$127M	-187.4%